Corticosteroid sparing agents in asthma

Hill, J M; Tattersfield, A E
May 1995
Thorax;May1995, Vol. 50 Issue 5, p577
Academic Journal
No abstract available.


Related Articles

  • Review: Adding antileukotrienes to inhaled corticosteroids reduces exacerbations in symptomatic chronic asthma. Rees, P. John // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p99 

    Comments on a study which investigated the addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Results; Treatment which reduces the rate of exacerbations that require systemic corticosteroids; Effects of inhaled corticosteroids on asthma.

  • Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry. Joan Sweeney; Chris E Brightling; Andrew Menzies-Gow; Robert Niven; Chris C Patterson; Liam G Heaney // Thorax;Aug2012, Vol. 67 Issue 8, p754 

    Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with...

  • Antileukotriene Drugs in Childhood Asthma: What is Their Place in Therapy? Selvadurai, H.; Mellis, C. // Pediatric Drugs;Sep/Oct2000, Vol. 2 Issue 5, p367 

    Leukotriene antagonists are a new class of anti-inflammatory drugs which have shown clinical efficacy in the management of asthma. However, their role in paediatric asthma is still unclear. In essence, while there are theoretical reasons as to why leukotriene antagonists would be of use in the...

  • The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE. Griffiths, Bridget; Emery, Paul; Ryan, Vicky; Isenberg, David; Akil, Mohammed; Thompson, Robert; Maddison, Peter; Griffiths, Ian D.; Lorenzi, Alice; Miles, Sarah; Situnayake, Deva; Lee Suan Teh; Plant, Mike; Hallengren, Christina; Nived, Ola; Sturfelt, Gunnar; Chakravarty, Kuntal; Tait, Tim; Gordon, Caroline // Rheumatology;Apr2010, Vol. 49 Issue 4, p723 

    Objective. To determine whether low-dose ciclosporin was a more effective corticosteroid-sparing agent than AZA in patients with SLE.

  • Review: Budesonide inhalation suspension. Holmes, Rafe; Browne, Barry // Drug Utilization Review;Apr2001, Vol. 17 Issue 4, p5 

    Evaluates the use of inhaled corticosteroids as an anti-inflammatory agent to help prevent recurrent asthma exacerbations. Demand for inhaled corticosteroid treatment; Government approval of Budesonide inhalation suspension; Pharmacologic effects of Budesonide.

  • Adverse effects of inhaled corticosteroids. Stead, R.J.; Cooke, N.J. // BMJ: British Medical Journal (International Edition);2/18/89, Vol. 298 Issue 6671, p403 

    Examines the severity of the adverse effect of inhaled corticosteroids. Use of the agent for prophylaxis in asthma; Occurrence of thrush during treatment; Investigation on the metabolic effect of the drug.

  • Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. Collins, Jennifer; deVos, Gabriele; Hudes, Golda; Rosenstreich, David // Journal of Asthma & Allergy;2012 Part 2, Vol. 5, p65 

    Background: Current therapy for allergic bronchopulmonary aspergillosis (ABPA) uses oral corticosteroids, exposing patients to the adverse effects of these agents. There are reports of the steroid-sparing effect of anti-IgE therapy with omalizumab for ABPA in patients with cystic fibrosis (CF),...

  • Statins in the treatment of asthma. WALKER, DERRICA Y.; EDWARDS, KRYSTAL L. // American Journal of Health-System Pharmacy;10/1/2013, Vol. 70 Issue 19, p1661 

    Purpose. Current evidence on statin agents as potential alternatives or adjuncts to corticosteroid therapy for asthma is reviewed. Summary. Research showing antiinflammatory and antioxidant effects of statins in animal models suggested that the cholesterol-lowering drugs might be useful in...

  • Drug Treatment of Asthma in the 1990s: Achievements and New Strategies. Tavakkoli, A.; Rees, P.J. // Drugs;Jan1999, Vol. 57 Issue 1, p1 

    Asthma is an inflammatory condition of the airways. First-line therapy involves the use of inhaled corticosteroids as anti-inflammatory agents to control the underlying process. Bronchodilators are used for symptom relief. Short-acting β-agonists provide rapid relief of bronchoconstriction,...

  • How effective are leukotriene inhibitors for asthma in children? Morden, Nancy E.; St. Anna, Leilani // Journal of Family Practice;Apr2004, Vol. 53 Issue 4, p325 

    explains that leukotrienes are potent mediators of inflammation and are believed to contribute significantly to the inflammatory pathophysiology of asthma. Leukotriene inhibitors interfere with leukotriene production or leukotriene receptors and thus inhibit inflammation. For children, the...


Read the Article


Sign out of this library

Other Topics